257 related articles for article (PubMed ID: 15616302)
1. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
3. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
Geller BL; Deere J; Tilley L; Iversen PL
J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
[TBL] [Abstract][Full Text] [Related]
4. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
6. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
[TBL] [Abstract][Full Text] [Related]
8. Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo.
Mellbye BL; Weller DD; Hassinger JN; Reeves MD; Lovejoy CE; Iversen PL; Geller BL
J Antimicrob Chemother; 2010 Jan; 65(1):98-106. PubMed ID: 19884121
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
Pannier AK; Arora V; Iversen PL; Brand RM
Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
[TBL] [Abstract][Full Text] [Related]
10. Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2.
Marshall NB; Hauck LL; Mourich DV
Methods Mol Biol; 2011; 764():153-68. PubMed ID: 21748639
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.
Amantana A; Iversen PL
Curr Opin Pharmacol; 2005 Oct; 5(5):550-5. PubMed ID: 16087398
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
13. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
14. Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation.
Iversen PL
Curr Opin Mol Ther; 2001 Jun; 3(3):235-8. PubMed ID: 11497346
[TBL] [Abstract][Full Text] [Related]
15. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.
Deas TS; Binduga-Gajewska I; Tilgner M; Ren P; Stein DA; Moulton HM; Iversen PL; Kauffman EB; Kramer LD; Shi PY
J Virol; 2005 Apr; 79(8):4599-609. PubMed ID: 15795246
[TBL] [Abstract][Full Text] [Related]
17. Variable coordination of cotranscribed genes in Escherichia coli following antisense repression.
Dryselius R; Nikravesh A; Kulyté A; Goh S; Good L
BMC Microbiol; 2006 Nov; 6():97. PubMed ID: 17118182
[TBL] [Abstract][Full Text] [Related]
18. The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli.
Dryselius R; Aswasti SK; Rajarao GK; Nielsen PE; Good L
Oligonucleotides; 2003; 13(6):427-33. PubMed ID: 15025910
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure.
Holden KL; Stein DA; Pierson TC; Ahmed AA; Clyde K; Iversen PL; Harris E
Virology; 2006 Jan; 344(2):439-52. PubMed ID: 16214197
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bacterial RNase P RNA as a drug target.
Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
